The Myeloid-Kidney Interface in Health and Disease
- 1 February 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 17 (2) , 323-331
Abstract
When producing articles for the Drug and Therapeutics Bulletin we seek comparative data on the drugs under discussion, and recommend the use of a product only if we think that on balance it offers advantages in terms of effectiveness, safety, convenience and (lastly) cost over other drugs or treatments already available. The Drug Costs symposium made it clear that the price of the drug alone indicates actual expenditure by the NHS only crudely, and that other variables (length of illness or stay in hospital, altered needs for surgery or investigations) need to be taken into account if real comparisons are to be made. The symposium also reminded prescribers that the price of branded drugs paid by the NHS depends on confidential negotiations between the Department of Health and individual drug companies through the Pharmaceutical Price Regulation Scheme (PPRS). Because negotiations are done in private it remains unclear how savings by prescribers are translated into savings to the NHS. Moreover the terms of the scheme encourage the proliferation of (‘me-too’) drugs, the setting of high prices at a drug’s launch, and the use of promotion that is aggressive.Keywords
Funding Information
- Canadian Institutes of Health Research (201911FBD-433120-DRA-CEDA-251523)
- Physicians' Services Incorporated Foundation (RT8-2021)
This publication has 90 references indexed in Scilit:
- Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy PatientsThe Journal of Immunology, 2012
- Myeloproliferative neoplasms cause glomerulopathyKidney International, 2011
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisNature Medicine, 2011
- Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus ErythematosusThe Journal of Immunology, 2011
- Macrophages in Renal DiseaseJournal of the American Society of Nephrology, 2011
- Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 DiabetesDiabetes, 2010
- Contrasting Effects of Steroids and Mizoribine on Macrophage Activation and Glomerular Lesions in Rat Thy-1 Mesangial Proliferative GlomerulonephritisAmerican Journal of Nephrology, 2010
- IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney InjuryJournal of the American Society of Nephrology, 2008
- Direct effects of dexamethasone on human podocytesKidney International, 2006
- Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injuryKidney International, 2004